Tudor Investment Corp
NPCE icon

Tudor Investment Corp’s Neuropace NPCE Stock Holding History

Tudor Investment Corp’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.78M Sell
135,705
-57,641
-30% -$865K ﹤0.01% 1929
2025
Q4 		$2.99M Buy
193,346
+39,648
+26% +$530K 0.01% 1516
2025
Q3 		$1.58M Buy
153,698
+34,807
+29% +$328K ﹤0.01% 1959
2025
Q2 		$1.32M Buy
118,891
+70,881
+148% +$886K ﹤0.01% 1953
2025
Q1 		$590K Buy
+48,010
New +$601K ﹤0.01% 2178

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Tudor Investment Corp's NPCE Position: Q1 2026 in Review

Tudor Investment Corp reduced its Neuropace (NPCE) stake by 30% in Q1 2026, selling an estimated $865K and leaving 135,705 shares worth $1.78M. The position accounts for ﹤0.01% of the portfolio, ranked #1929.

Tudor Investment Corp first reported a position in NPCE in Q1 2025 and has held it in 5 quarters since. The position peaked at $2.99M in Q4 2025. 113 funds tracked by Wall St. Rank hold NPCE as of Q1 2026.

  • Tudor Investment Corp held 135,705 shares of Neuropace worth $1.78M as of Q1 2026.
  • Tudor Investment Corp sold 57,641 Neuropace shares in Q1 2026, an estimated $865K.
  • Neuropace made up ﹤0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #1929 holding.
  • Tudor Investment Corp first reported a position in Neuropace in Q1 2025 and has held it in 5 quarters since.
  • Tudor Investment Corp's Neuropace position peaked at $2.99M in Q4 2025.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.